Abstract
Concomitant antibiotic use during treatment for Clostridium difficile infection (CDI) increases the risk of recurrence. Across a network of children’s hospitals, 46% of patients treated for CDI received concomitant antibiotics for a median of 7 days. Concomitant antibiotic use was more common among patients with malignancies, and solid organ or bone marrow transplant. Unnecessary concomitant antibiotic use in CDI patients is a potential target for pediatric antimicrobial stewardship.
Original language | English |
---|---|
Pages (from-to) | 45-51 |
Number of pages | 7 |
Journal | Infectious Diseases and Therapy |
Volume | 5 |
Issue number | 1 |
DOIs | |
State | Published - Mar 1 2016 |
Keywords
- Clostridium difficile infection
- Concomitant antibiotics
- Pediatric